DAXOR CORPORATION - CL

Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference

16 3 2021 07:30:00 提供 Nasdaq GlobeNewswire

DAXOR CORPORATION ANNOUNCES NOVEL FLUORESCENT TRACER AND PHASE-TWO US AIR FORCE CONTRACT AWARD OF $750,000 FOR POINT-OF-CARE OPTICAL BLOOD VOLUME ANALYZER

15 3 2021 07:30:00 提供 Nasdaq GlobeNewswire

Daxor to Present at the H.C. Wainwright Global Life Sciences Conference

04 3 2021 07:30:00 提供 Nasdaq GlobeNewswire

Daxor Corporation Announces $0.48 Per Share NAV Increase and Files Annual Report for Fiscal 2020

26 2 2021 07:30:00 提供 Nasdaq GlobeNewswire

DAXOR CORPORATION RECEIVES ISO 13485 QUALITY MANAGEMENT SYSTEM CERTIFICATION FOR THE BLOOD VOLUME ANALYZER (BVA-100®)

19 2 2021 07:30:00 提供 Nasdaq GlobeNewswire

DAXOR CORPORATION AWARDED GRANT FROM THE CENTER FOR ADVANCING POINT OF CARE TECHNOLOGIES (CAPCAT) TO DEVELOP A POINT-OF-CARE BLOOD VOLUME ANALYZER

05 2 2021 07:30:00 提供 Nasdaq GlobeNewswire

New Research Demonstrates the Clinical Utility with Daxor’s Blood Volume Analyzer (BVA-100®) in Critical Care

04 2 2021 07:30:00 提供 Nasdaq GlobeNewswire

DAXOR CORPORATION TO EXHIBIT AT THE SOCIETY FOR CRITICAL CARE MEDICINE 50TH CONGRESS VIRTUAL EVENT

26 1 2021 07:30:01 提供 Nasdaq GlobeNewswire

DAXOR ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH L1 ENTERPRISES GOVERNMENT DISTRIBUTOR

13 1 2021 07:30:00 提供 Nasdaq GlobeNewswire

Daxor to Present at the Inaugural H.C. Wainwright BioConnect 2021 Conference

08 1 2021 07:30:00 提供 Nasdaq GlobeNewswire